Stereotaxis, Inc.
AMEX:STXSMedical - Instruments & Supplies
+$0.05 today
- Market cap
- $94.80M
- Beta
- 1.32
- P/E (TTM)
- -8.3
- EPS (TTM)
- -$0.22
Volume 0.90M
Average 0.39M
STXS Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Stereotaxis, Inc.AMEX: STXS
Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026
Deferred revenue falls 17.6% from a year ago
Deferred revenue stood at $7.59M at the end of Q1 FY2026, down 17.6% from a year earlier and up 12.9% from the prior quarter. Over 3 fiscal years it compounded at -2.9% a year.
Context
- Deferred revenue amounted to 14.0% of total assets at the end of Q1 FY2026, down 6.1 pp from a year earlier.
- Deferred revenue increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether deferred revenue keeps falling in the next quarterly balance sheet after a -17.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 6.72M USD
- Year-over-year change
- -14.4%
- 4-year CAGR
- +1.7%
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.72M | -14.4% |
| FY2024 | 2024-12-31 | 7.85M | +1.9% |
| FY2023 | 2023-12-31 | 7.7M | +4.9% |
| FY2022 | 2022-12-31 | 7.34M | +17.0% |
| FY2021 | 2021-12-31 | 6.28M | — |
Deferred Revenue vs competitors
How STXS compares with its peers on the latest reported figures
- STXS's Mar 2026 deferred revenue of $7.59M is the highest of the 5 companies compared; the peer median is $970K.
- Its year-over-year change of -17.6% is the 3rd highest of 4, against a peer median of +12.1%.
- Deferred revenue amounts to 14.0% of total assets for STXS, versus a peer median of 1.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $7.59M | -17.6% | -2.9% | 14.0% | |
| Mar 2026 | $3.58M | +91.5% | +1125.2% | 4.0% | |
| Mar 2026 | $1.81M | +12.1% | +16.1% | 1.9% | |
| Mar 2026 | $126K | -81.5% | — | 0.1% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding STXS) | $970K | +12.1% | +570.7% | 1.0% | |
Competitors are the stored peer set for STXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 38.74M | 8.59M | 19.82M | 12.22M | 13.42M |
| Short-term Investments | 0 | 19.84M | 0 | 0 | 0 |
| Net Receivables | 5.41M | 5.09M | 3.82M | 3.82M | 10.16M |
| Inventory | 4.43M | 7.88M | 8.43M | 8.33M | 9.57M |
| Other Current Assets | 570K | 525K | 623K | 1.28M | 698K |
| Total Current Assets | 51.39M | 43.25M | 33.27M | 26.44M | 33.85M |
| Property, Plant & Equipment (Net) | 8.37M | 9.22M | 8.29M | 9.06M | 7.93M |
| Goodwill | 0 | 0 | 0 | 3.76M | 3.76M |
| Intangible Assets | 0 | 0 | 0 | 7.36M | 6.43M |
| Long-term Investments | 0 | 0 | 219K | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.23M | 952K | 137K | 107K | 278K |
| Total Non-current Assets | 9.6M | 10.17M | 8.64M | 20.29M | 18.4M |
| Total Assets | 60.99M | 53.41M | 41.91M | 46.72M | 52.25M |
| Account Payables | 4.19M | 3.27M | 3.19M | 5.67M | 4.77M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 177K | 47K | 0 | 0 | 0 |
| Deferred Revenue | 6.28M | 7.34M | 7.7M | 7.85M | 6.72M |
| Other Current Liabilities | 0 | 163K | 0 | 4.59M | 4.89M |
| Total Current Liabilities | 13.26M | 14.29M | 13.25M | 21.6M | 22.36M |
| Long-term Debt | 0 | 0 | 0 | 0 | 4.79M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 2.24M | 1.65M | 1.64M | 2.06M | 555K |
| Other Non-current Liabilities | 218K | 51K | 43K | 6.19M | 5.82M |
| Total Non-current Liabilities | 8.3M | 7.19M | 6.74M | 13.69M | 11.17M |
| Total Liabilities | 21.56M | 21.48M | 19.99M | 35.29M | 33.53M |
| Common Stock | 75K | 75K | 81K | 85K | 95K |
| Retained Earnings | (498.68M) | (516.97M) | (537.68M) | (561.73M) | (583.37M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 39.43M | 31.93M | 21.92M | 11.43M | 18.72M |
| Total Debt | 6.11M | 5.86M | 5.49M | 6.01M | 5.44M |
| Net Debt | (32.63M) | (2.73M) | (14.33M) | (6.21M) | (7.99M) |
Stereotaxis, Inc.
AMEX:STXS
Intrinsic Alpha fair value
Locked
Current Price
$0.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.